Kaitlin M Dailey

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Oxide Nanoparticles

Top Venues

Future microbiology

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kaitlin M Dailey, James M Small, Jessica E Pullan, Seth Winfree, Krysten E Vance, Megan Orr, Sanku Mallik, Kenneth W Bayles, Michael A Hollingsworth, Amanda E Brooks
An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. PloS one 18 (11) (2023)
Jason M Roe, Kevin D Seely, Caleb J Bussard, Emily Eischen Martin, Elizabeth G Mouw, Kenneth W Bayles, Michael A Hollingsworth, Amanda E Brooks, Kaitlin M Dailey
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria. Pharmaceutics 15 (7) (2023)
Kyle M Pierce, William R Miklavcic, Kyle P Cook, Mikayla Sweitzer Hennen, Kenneth W Bayles, Michael A Hollingsworth, Amanda E Brooks, Jessica E Pullan, Kaitlin M Dailey
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel, Switzerland) 11 (11) (2021)
Kaitlin M Dailey, JuliAnne E Allgood, Paige R Johnson, Mackenzie A Ostlie, Kambri C Schaner, Benjamin Rix Brooks, Amanda E Brooks
The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering. Future microbiology 16 (2021)